Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA’s DTC Principles: After Two Years, Still A Work In Progress

Executive Summary

According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice

You may also be interested in...



Drug Firms To Adopt AMA Guidelines On Physicians In DTC Ads

Four leading drug companies have pledged to follow American Medical Association guidelines on portraying physicians in direct-to-consumer ads, which may lead to broader adoption of the principles by other firms

Drug Firms To Adopt AMA Guidelines On Physicians In DTC Ads

Four leading drug companies have pledged to follow American Medical Association guidelines on portraying physicians in direct-to-consumer ads, which may lead to broader adoption of the principles by other firms

Rep. Dingell’s Prescription For DTC Offered To Pharma Panel At Hearing

House Energy and Commerce Committee Chairman John Dingell, D-Mich., outlined several precepts for enhancing direct-to-consumer drug advertising at a May 8 hearing by the Energy and Commerce Oversight and Investigations Subcommittee

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel